Recently Viewed

News Announcement

Shreekrishna Biotech: Statement Of Investor Complaints For The Quarter Ended December,2017

04-Jan-2018 Follow Value Research Online on Google Shreekrishna Biot

Pursuant to Regulation 13 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below Statement of Investor Complaints for the quarter ended December 31, 2017.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan